Top Qs
Timeline
Chat
Perspective
Cendakimab
Pharmaceutical compound From Wikipedia, the free encyclopedia
Remove ads
Cendakimab (RPC4046; ABT 308; CC-93538) is a monoclonal antibody against interleukin 13. It is developed by Bristol Myers Squibb[1] for eosinophilic esophagitis.[2][3][4]
Remove ads
References
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads